Subscribe To

Price Alert Latest News Economic Calendar News

GRX / GRX: There Are Better Alternatives In The Healthcare CEF Sector

The Gabelli Healthcare & WellnessRx Trust is an underperforming equity closed-end fund (CEF) focused on healthcare stocks. GRX has a -19% discount to net asset value, but has traded at very substantial discounts for the past five years. The fund employs a 27% leverage ratio, which has hampered its performance in 2023. Read More

Demo Live Account See Partner Details

Content Topics

GRX

There

Better

Alternatives

Healthcare

Sector

Stock

Posted: Nov 3 2023, 07:23

Author Name: Seeking Alpha

GRX News

By Seeking Alpha
November 3, 2023

GRX: There Are Better Alternatives In The Healthcare CEF Sector

The Gabelli Healthcare & WellnessRx Trust is an underperforming equity closed-end fund (CEF) focused on healthcare stocks. GRX has a -19% discount to

By Seeking Alpha
August 15, 2023

GRX: Modest Healthcare Fund Trading At A Steep Discount

The Gabelli Healthcare & Wellness Rx Trust seeks to provide capital gains and income from a portfolio of healthcare and wellness-focused stocks. The f

By Seeking Alpha
March 20, 2023

GRX: High-Yielding CEF Available At Discount, Suits Income-Seeking Investors

The Gabelli Healthcare & Wellness Rx Trust generates above-average yield and is available at a huge discount. However, its annual average total return

By Seeking Alpha
December 14, 2022

GRX: Lagging Peers, But Discount Is Attractive

If you compare GRX to other healthcare peers, it has underperformed. However, GRX isn't focused solely on healthcare, so its portfolio has a bit more

By Seeking Alpha
December 14, 2022

GRX: Steady Yield And Returns, Portfolio Looks Impressive After Restructuring

Between 2017 and 2021, GRX generated a yield of 5.2 percent and total return of 12 percent. It recorded positive returns in 8 out of the past 10 years

By Seeking Alpha
May 9, 2022

GRX: Not Among The Best Closed-End Healthcare-Based Funds

GRX's total return has been negative, and yield has been quite average over the short term. GRX failed to record double digit average total return ove

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.